Definitive Healthcare Corp.
NASDAQ:DHMedical - Healthcare Information Services
+$0.01 today
- Market cap
- $143.60M
- Beta
- 1.33
- P/E (TTM)
- -0.5
- EPS (TTM)
- -$1.63
Volume 0.43M
Average 0.32M
DH EBITDA Margin
EBITDA as a percentage of revenue.
Definitive Healthcare Corp.NASDAQ: DH
EBITDA Margin · Q1 FY2026 · quarter ended Mar 2026
EBITDA Margin widens to 15.0%
EBITDA Margin was 15.0% in Q1 FY2026, up 268.0 pp from a year earlier. On a trailing-twelve-month basis it was 4.9%, up 295.3 pp year over year. Over 3 fiscal years it narrowed by 78.9 pp.
Context
- EBITDA Margin widened in 1 of the last 3 fiscal years.
What to watch
Whether EBITDA Margin reaches the consensus estimate from 3 analysts of 40.1% for the fiscal year ending Dec 2026, up from -67.1% in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- 15.0%+23.4 pp QoQ
- Last fiscal yearDec 2025
- -67.1%+157.8 pp YoY
- LTMMar 2026
- 4.9%+295.3 pp YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- -67.1%
- Year-over-year change
- +157.8pp
| Period | Period end | EBITDA Margin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | -67.1% | +157.8pp |
| FY2024 | 2024-12-31 | -224.9% | -129.0pp |
| FY2023 | 2023-12-31 | -95.9% | -107.7pp |
| FY2022 | 2022-12-31 | 11.8% | -2.1pp |
| FY2021 | 2021-12-31 | 13.9% | — |
EBITDA Margin vs competitors
How DH compares with its peers on the latest reported figures
- DH's LTM Mar 2026 EBITDA Margin of 4.9% is the 5th highest of the 8 companies compared; the peer median is 9.4%.
- Its year-over-year change of +295.3 pp is the 2nd highest of 8, against a peer median of -3.3 pp.
- Over three fiscal years its change of -78.9 pp compares with a peer median of -2.4 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Feb 2026 | 21.5% | +0.4 pp | -16.1 pp | |
| LTM Mar 2026 | 20.1% | -9.1 pp | -10.5 pp | |
| LTM Mar 2026 | 16.3% | -1.8 pp | +14.4 pp | |
| LTM Mar 2026 | 9.4% | -3.3 pp | -2.4 pp | |
| LTM Mar 2026 | 4.9% | +295.3 pp | -78.9 pp | |
| LTM Mar 2026 | -81.4% | -6.3 pp | +87.8 pp | |
| LTM Mar 2026 | -258.7% | +387.8 pp | +719.4 pp | |
| LTM Mar 2026 | -7060.9% | -6900.9 pp | -2402.8 pp | |
| FY2025 | — | — | — | |
| FY2025 | — | — | — | |
| Peer median (excluding DH) | 9.4% | -3.3 pp | -2.4 pp | |
Competitors are the stored peer set for DH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 166.15M | 222.65M | 251.42M | 252.2M | 241.52M |
| Cost of Revenue | 40.69M | 42.63M | 47.48M | 54.73M | 58.25M |
| Gross Profit | 125.47M | 180.03M | 203.93M | 197.47M | 183.28M |
| Gross Margin | 75.5% | 80.9% | 81.1% | 78.3% | 75.9% |
| Research & Development | 18.57M | 34.89M | 42.44M | 36.52M | 34.78M |
| Selling, General & Admin | 89.25M | 141.15M | 153.4M | 133.07M | 133.26M |
| Operating Expenses | 152.78M | 224.07M | 533.73M | 908.29M | 203.86M |
| Depreciation & Amortization | 59.95M | 56.9M | 51.75M | 51.67M | 35.82M |
| EBITDA | 23.08M | 26.23M | (241.23M) | (567.24M) | (162.15M) |
| EBITDA Margin | 13.9% | 11.8% | -95.9% | -224.9% | -67.1% |
| Operating Income | (27.32M) | (44.04M) | (329.8M) | (710.82M) | (20.58M) |
| Operating Margin | -16.4% | -19.8% | -131.2% | -281.8% | -8.5% |
| Interest Income | 29K | 2.79M | 13.64M | 14.59M | 6.95M |
| Interest Expense | 25.9M | 11.2M | 15.2M | 14.84M | 11.29M |
| Other Income / Expenses | (35.45M) | 2.17M | 21.62M | 77.08M | (188.67M) |
| Income Before Tax | (62.77M) | (41.88M) | (308.18M) | (633.75M) | (209.26M) |
| Pre-Tax Margin | -37.8% | -18.8% | -122.6% | -251.3% | -86.6% |
| Income Tax Expense | (443K) | (17.7M) | (18.55M) | (42.3M) | (9.96M) |
| Net Income | (51.91M) | (7.22M) | (202.39M) | (413.12M) | (138.93M) |
| Net Margin | -31.2% | -3.2% | -80.5% | -163.8% | -57.5% |
| EPS (Basic) | (0.19) | (0.07) | (1.79) | (3.54) | (1.30) |
| EPS (Diluted) | (0.19) | (0.07) | (1.79) | (3.54) | (1.30) |
| Weighted Avg Shares | 97.03M | 101.11M | 112.76M | 116.64M | 106.65M |
| Weighted Avg Shares (Diluted) | 97.03M | 101.11M | 112.76M | 116.64M | 106.65M |
Definitive Healthcare Corp.
NASDAQ:DH
Intrinsic Alpha fair value
Locked
Current Price
$1.34
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.